Clinical Trial Update: L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether L-arginine reduces sympathetic nerve activity in patients with chronic kidney disease. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: The University of Texas at Arlington | Conditions: Chronic Kidney Disease | Phase 4 | Status: RECRUITING